Early Detection of Alzheimers for Drug Companies

Our Prion Early Detection Science accelerates drug development to finding a cure for Alzheimer’s and Parkinson’s.

How can Amprion help accelerate the development of a new generation of successful drugs for Alzheimer’s and Parkinson’s?

Our Prion Early Detection Science replicates the process of protein misfolding that drives the progression of Alzheimer’s and Parkinson’s, which usually takes 10-30 years in the brain down to a few hours in the laboratory.

As a result, Amprion aims to design custom assays for pharmaceutical companies that optimize rapid design and selection of new drugs based on the chemical structure of these drugs.

How Amprion Helps Drug Companies

GET UPDATES

GET UPDATES ON TESTING AVAILABILTY,

BRAIN HEALTH INFO AND FOLLOW AMPRION’S PROGRESS.


I'm a DoctorI'm a Neurologistother, please specify